Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-canonical β-adrenergic activation of ERK at endosomes. | Nature | 2022 | 36289326 | PubTator, text mining | PubMed |
| Predictive models for musculoskeletal injury risk: why statistical approach makes all the difference. | BMJ Open Sport Exerc Med | 2022 | 36268503 | PubTator, text mining | PubMed |
| Dissection of the Active Ingredients and Potential Mechanism of Han-Shi-Yu-Fei-Decoction in Treating COVID-19 Based on In Vivo Substances Profiling and Clinical Symptom-Guided Network Pharmacology. | ACS Omega | 2022 | 36268464 | PubTator, text mining | PubMed |
| Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis. | J Oncol | 2022 | 36268282 | PubTator, text mining | PubMed |
| Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling. | Elife | 2022 | 36250629 | PubTator, text mining | PubMed |
| Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease. | Front Med (Lausanne) | 2022 | 36250074 | PubTator, text mining | PubMed |
| Case Report: Left atrial myxoma with confirmed Delta variant COVID-19 infection, "to treat or withhold". | F1000Res | 2022 | 36250001 | PubTator, text mining | PubMed |
| The Incidence and Risk Factors of Hyponatremia in Pulmonary Tuberculosis. | J Endocr Soc | 2022 | 36249414 | PubTator, text mining | PubMed |
| Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality. | Heliyon | 2022 | 36247169 | PubTator, text mining | PubMed |
| Pathophysiology of Drug-Induced Hyponatremia. | J Clin Med | 2022 | 36233678 | PubTator, text mining | PubMed |
| Novel Long-Acting Oxytocin Analog with Increased Efficacy in Reducing Food Intake and Body Weight. | Int J Mol Sci | 2022 | 36232550 | PubTator, text mining | PubMed |
| Persistence of tolvaptan medication for autosomal dominant polycystic kidney disease: A retrospective cohort study using Shizuoka Kokuho Database. | Medicine (Baltimore) | 2022 | 36221375 | PubTator, text mining | PubMed |
| A Novel AQP2 Sequence Variant Causing Aquaporin-2 Retention in the Cytoplasm and Autosomal Dominant Nephrogenic Diabetes Insipidus. | Kidney Int Rep | 2022 | 36217530 | PubTator, text mining | PubMed |
| Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment. | Hepat Med | 2022 | 36200122 | PubTator, text mining | PubMed |
| Predicting the number of citations of polycystic kidney disease with 100 top-cited articles since 2010: Bibliometric analysis. | Medicine (Baltimore) | 2022 | 36197211 | PubTator, text mining | PubMed |
| Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus. | FASEB J | 2022 | 36197017 | PubTator, text mining | PubMed |
| Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do. | J Multidiscip Healthc | 2022 | 36193191 | PubTator, text mining | PubMed |
| Secondary hormonal alterations in short-term severe hypothyroidism; in the focus: Apelin and copeptin. | Front Endocrinol (Lausanne) | 2022 | 36187132 | PubTator, text mining | PubMed |
| Dysregulated DNA methylation in the pathogenesis of Fabry disease. | Mol Genet Metab Rep | 2022 | 36186841 | PubTator, text mining | PubMed |
| Modular derivation of diverse, regionally discrete human posterior CNS neurons enables discovery of transcriptomic patterns. | Sci Adv | 2022 | 36179024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=23